BrainStorm Cell Therapeutics
BCLI
#10412
Rank
A$8.89 M
Marketcap
A$0.81
Share price
-3.57%
Change (1 day)
-75.44%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -A$16.97 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$17.35 Million, an increase over its 2023 earnings that were of -A$25.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$16.97 Million-2.19%
2024 -A$17.35 Million-32.39%
2023 -A$25.66 Million-29.18%
2022 -A$36.24 Million-0.74%
2021 -A$36.5 Million-23.12%
2020 -A$47.48 Million36.8%
2019 -A$34.71 Million66.71%
2018 -A$20.82 Million181.66%
2017 -A$7.4 Million-0.6%
2016 -A$7.44 Million-41.31%
2015 -A$12.67 Million-8.22%
2014 -A$13.81 Million89.74%
2013 -A$7.28 Million42.27%
2012 -A$5.12 Million-12.45%
2011 -A$5.84 Million63.04%
2010 -A$3.59 Million35.52%
2009 -A$2.65 Million-48.99%
2008 -A$5.19 Million-44.39%
2007 -A$9.32 Million
2005 -A$4.83 Million-91.44%
2004 -A$56.39 Million94007.62%
2003 -A$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.75 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.13 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.18 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.84 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$30.83 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.39 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA